In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...